ENA Respiratory has begun dosing participants in Part B of [...]
AstraZeneca is evaluating its oral IRAK4 inhibitor AZD6793 in a [...]
AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]
The World Bronchiectasis Conference (WBC) will return to Hannover, Germany, [...]
NICE has issued draft final guidance recommending Nucala as an [...]
Evonik and Ethris have agreed a partnership to develop and [...]